In this study, we found that deficiency of FcRγ resulted in increased survival in lipopolysaccharide (LPS)/D-galactosamine andE. coli-induced sepsis in mice. This protective effect was characterized by decreased TNF- α, IL-6, and IL-10. Further experiments in bone marrow-derived macrophages (BMDMs) in vitro also showed that FcRγ deficiency resulted in decreased production of TNF-α, IL-6, and IL-10 upon LPS stimulation. The mechanism study showed that FcRγ was physiologically associated with toll-like recepto r 4 (TLR4), and tyrosine phosphorylation of FcRγ mediated TLR4 signaling pathway, followed by increased ERK phosphorylation upon LPS stimulation. Our results suggest that FcRγ might be a potential therapeutic target of sepsis. (Source: Immunologic Research)
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2A0ioBM
Παρασκευή 14 Δεκεμβρίου 2018
FcR γ deficiency improves survival in experimental sepsis by down-regulating TLR4 signaling pathway
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.